Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Common Equity (2017 - 2025)

Inspire Medical Systems (INSP) has disclosed Common Equity for 9 consecutive years, with $781.2 million as the latest value for Q4 2025.

  • Quarterly Common Equity rose 13.26% to $781.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $781.2 million through Dec 2025, up 13.26% year-over-year, with the annual reading at $781.2 million for FY2025, 13.26% up from the prior year.
  • Common Equity hit $781.2 million in Q4 2025 for Inspire Medical Systems, up from $666.5 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $781.2 million in Q4 2025 to a low of $219.9 million in Q2 2021.
  • Historically, Common Equity has averaged $491.8 million across 5 years, with a median of $536.8 million in 2023.
  • Biggest five-year swings in Common Equity: decreased 5.86% in 2021 and later skyrocketed 133.21% in 2023.
  • Year by year, Common Equity stood at $229.0 million in 2021, then skyrocketed by 116.55% to $496.0 million in 2022, then grew by 15.42% to $572.5 million in 2023, then grew by 20.47% to $689.7 million in 2024, then grew by 13.26% to $781.2 million in 2025.
  • Business Quant data shows Common Equity for INSP at $781.2 million in Q4 2025, $666.5 million in Q3 2025, and $677.8 million in Q2 2025.